A Consensus for Pituitary Adenoma Diagnosis in Indonesia
DOI:
https://doi.org/10.15605/jafes.040.01.03Keywords:
pituitary adenoma, clinical practice guidelines, indonesiaAbstract
Pituitary adenomas account for 10 to 15% of all intracranial masses and are the most common type of pituitary disorder. Their clinical manifestations can vary based on the tumor size and whether they secrete excess hormones. Occasionally, they are incidentally diagnosed following an imaging procedure for other indications (pituitary incidentaloma). The Pituitary Working Group of the Indonesian Society of Endocrinology has identified pituitary adenoma as a priority and has called for the development of updated evidence-based practice guidelines. These guidelines aim to provide evidence-based, comprehensive and multidisciplinary recommendations for diagnosing pituitary adenomas in Indonesia and to navigate the limitations of diagnosing pituitary adenomas in Indonesia.
Downloads
References
1. Banskota S, Adamson DC. Pituitary adenomas: From diagnosis to therapeutics. Biomedicines. 2021;9(5):494. https://pubmed.ncbi.nlm.nih.gov/33946142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146984 https://doi.org/10.3390/biomedicines9050494
2. Araujo-Castro M, Rodríguez Berrocal V, Pascual-Corrales E. Pituitary tumors : Epidemiology and clinical presentation spectrum. Hormones (Athens). 2020;19(2):145-55. https://pubmed.ncbi.nlm.nih.gov/31933100 https://doi.org/10.1007/s42000-019-00168-8
3. Gittleman H, Ostrom QT, Farah PD, et al. Descriptive epidemiology of pituitary tumors in the united states, 2004–2009. J Neurosurg. 2014;121(3):527–35. https://pubmed.ncbi.nlm.nih.gov/24926650 https://doi.org/10.3171/2014.5.JNS131819
4. Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382(10):937–50. https://pubmed.ncbi.nlm.nih.gov/32130815 https://doi.org/10.1056/NEJMra1810772
5. Molitch ME. Diagnosis and treatment of pituitary adenomas a review. JAMA. 2017;317(5):516–24. https://pubmed.ncbi.nlm.nih.gov/28170483 https://doi.org/10.1001/jama.2016.19699
6. Lake MG. Pituitary adenomas: An overview. Am Fam Physician. 2013;88(5):319–27. https://pubmed.ncbi.nlm.nih.gov/24010395
7. Cahyanur R, Soewondo P, Darmowidjojo B, Ananda Aman R, Dewiasty E. Gambaran Klinis dan Proporsi Hipotiroidisme Sekunder pada Pasien Adenoma Hipofisis di Rumah Sakit Cipto Mangunkusumo. J Indones Med Assoc Maj Kedokt Indones. 2018;68(6):216–22. https://doi.org/10.47830/jinma-vol.68.6-2018-57
8. Kline G, Chin AC. Adrenal disorders. In: Endocrine biomarkers: Clinicians and clinical chemists in partnership. Elsevier Inc.; 2017
9. Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K. Aggressive pituitary adenomas — diagnosis and emerging treatments. Nat Rev Endocrinol. 2014;10(7):423-35. https://pubmed.ncbi.nlm.nih.gov/24821329 https://doi.org/10.1038/nrendo.2014.64
10. Greenberg MS, Residency N, Program T, Repair B. Handbook of neurosurgery. 9th ed. New York: Thieme Medical Publishers; 2020.
11. Chanson P, Raverot G, Cortet-rudelli C, Salenave S. Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris). 2015;76(3):239-47. https://pubmed.ncbi.nlm.nih.gov/26072284 https://doi.org/10.1016/j.ando.2015.04.002:239–47.
12. Zhang J, Zhang S, Song Y, et al. Predictive value of preoperative retinal nerve fiber layer thickness for postoperative visual recovery in patients with chiasmal compression. Oncotarget. 2017;8(35):59148–55. https://pubmed.ncbi.nlm.nih.gov/28938625 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601721 https://doi.org/10.18632/oncotarget.19324
13. Lachowicz E, Lubiński W. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: An overview. Doc Ophthalmol. 2018;137(3):193-202. https://pubmed.ncbi.nlm.nih.gov/30374652 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244962 https://doi.org/10.1007/s10633-018-9659-5
14. Sun M, Zhang ZQ, Chen SY, Chen SH, CHen XJ. Predictive factors of visual function recovery after pituitary adenoma resection: A literature review and meta-analysis. Int J Ophthalmol. 2017;10(11):1742-50. https://pubmed.ncbi.nlm.nih.gov/29181320 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686375 https://doi.org/10.18240/ijo.2017.11.17
15. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904. https://pubmed.ncbi.nlm.nih.gov/21474686 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422 https://doi.org/10.1210/jc.2010-1048
16. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28(1):81–117. https://pubmed.ncbi.nlm.nih.gov/10207686 https://doi.org/10.1016/s0889-8529(05)70058-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dicky Levenus Tahapary, Selfy Oswari, Maya Kusumawati, Dian Anindita Lubis, Tania Tedjo Minuljo, Reyhan Eddy Yunus, Henry Kodrat, Affan Priyambodo Permana, Martha Rosana, Johanes Purwoto, Leny Puspitasari, Hermina Novida, Himawan Sanusi, Syntia Nusanti, Tri Juli Edi Tarigan, Pradana Soewondo, Ketut Suastika
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
